Recent Cancer Cell Atlas Could Accelerate Treatment Development
An international team of scientists has created a comprehensive atlas of mouse cancer cell lines, a resource expected to significantly advance cancer research and the development of new therapies. The atlas, containing nearly 600 models of tumor cells, is now publicly available to researchers worldwide.
The project, recently published in the prestigious journal Nature, includes detailed genetic information and other data for each cell line, allowing scientists to study how tumors develop and respond to treatment. This detailed mapping of cancer cells is a crucial step toward understanding the complexities of the disease and finding more effective ways to combat it.
Daniel Alonso, director of the Center of Molecular and Translational Oncology at the National University of Quilmes in Argentina, was the sole Latin American representative involved in the study. Alonso, who also works with the National Scientific and Technical Research Council (CONICET), explained that a “cell line is having place to grow in vitro, that is, in the laboratory, cancerous cells of each type of cancer.” These cultures can then be maintained indefinitely, frozen for preservation, or transplanted into animals to create in vivo models for studying the disease.
Researchers used the atlas to investigate why mutations in a specific gene, KRAS, can contribute to cancer development in some tissues but not others. According to reports, the mouse models are valuable since they closely mimic the disease as it manifests in humans, including physiological and immune system responses.
The atlas is an open-access database, meaning This proves freely available to scientists and the public. Researchers from CONICET highlight that this resource will accelerate the pace of cancer research and potentially lead to the development of more targeted and effective treatments.
